SCHEMBL6964468

SCHEMBL6964468

CC(C)c1ccccc1Sc1c(O)cc(-c2ccc(-c3cccnc3)cc2)oc1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP1 O94782 7/20 0.36
WDR48 Q8TAF3 6/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
POLB P06746 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ERN1 O75460 1/20 0.36
USP2 O75604 1/20 0.35
USP8 P40818 1/20 0.35
OTUB1 Q96FW1 1/20 0.35
USP36 Q9P275 1/20 0.35
CYP19A1 P11511 2/20 0.35
MKNK1 Q9BUB5 1/20 0.35
MKNK2 Q9HBH9 1/20 0.35
CYP17A1 P05093 1/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
TNKS O95271 1/20 0.34
PARP1 P09874 1/20 0.34
TNKS2 Q9H2K2 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6960294 0.88 QPCT (0.39) SMN1; SMN2POLBL3MBTL1TNKSPARP1
SCHEMBL6961039 0.87 SMN1; SMN2 (0.46) SMN1; SMN2POLBL3MBTL1USP2CYP19A1
SCHEMBL6963494 0.85 PTGES (0.43) SMN1; SMN2POLBL3MBTL1USP2CYP19A1
SCHEMBL6959848 0.84 ADAMTS4 (0.40) SMN1; SMN2MAOBLMNAMAPK1
SCHEMBL6964073 0.84 AR (0.41) SMN1; SMN2POLBL3MBTL1TNKSPARP1
SCHEMBL6954281 0.83 ALDH1A1 (0.42) SMN1; SMN2POLBL3MBTL1TNKSPARP1
SCHEMBL6960601 0.83 AR (0.41) SMN1; SMN2POLBL3MBTL1TNKSPARP1
Cyclohexane SCHEMBL6955484 0.82 ADAMTS4 (0.39) MAOBLMNAMAPK1
Cyclopentane SCHEMBL6955464 0.82 ADAMTS4 (0.39) MAOBLMNAMAPK1
Cyclopropane SCHEMBL6955630 0.82 ADAMTS4 (0.39) MAOBLMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed